Cellectar Biosciences, Inc. Series A Warrants
CLRBZ
CLRBZ was delisted on the 16th of April, 2021.
2 hedge funds and large institutions have $124K invested in Cellectar Biosciences, Inc. Series A Warrants in 2016 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
14% less capital invested
Capital invested by funds: $145K → $124K (-$21K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Ionic Capital Management
New York
|
-$1.17K |
CLRBZ Hedge Fund Activity: Q3 2016 in Review
2 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Cellectar Biosciences, Inc. Series A Warrants (CLRBZ) for Q3 2016, worth a combined $124K — down 14% from $145K a quarter earlier.
Fund positioning in CLRBZ was balanced in Q3 2016: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was Ionic Capital Management, cutting an estimated $1.17K.
- 2 institutional investors held Cellectar Biosciences, Inc. Series A Warrants (CLRBZ) as of Q3 2016, unchanged from Q2 2016.
- Funds reported $124K of Cellectar Biosciences, Inc. Series A Warrants stock for Q3 2016, down 14% quarter-over-quarter.
- 0 funds opened new Cellectar Biosciences, Inc. Series A Warrants positions in Q3 2016 and 0 closed out.
- The largest Cellectar Biosciences, Inc. Series A Warrants seller in Q3 2016 was Ionic Capital Management, an estimated $1.17K sold.
Based on aggregated 13F filings for Q3 2016.